Byung Wook Min

Byung Wook Min

Auto-generated profile, based on publicly available information

Byung Wook Min

Division of Colorectal Surgery, Department of Surgery, Korea University College of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Medicine
Verified
Journal Article
Open access
PDF file
Sanghee KangSanghee Kang
Sanghee Kang
YNYounghyun Na
Younghyun Na
SJSung Yup Joung
Sung Yup Joung
SLSun Il Lee
Sun Il Lee
SOSang Cheul Oh
Sang Cheul Oh
BMByung Wook Min
Byung Wook Min
The colorectal cancer (CRC) patients with microsatellite instability (MSI) have distinct clinicopathological characteristics consisting of factors predicting positive and negative outcomes, such as a high lymph node harvest and poor differentiation. In this study, we measured the value of MSI as a prognostic factor after controlling for these discrepant factors. A total of 603 patients who underwent curative surgery for stages I to III colorectal cancer were enrolled. The patients were divided into microsatellite instability high (MSI-H) and microsatellite stable/microsatellite instability low (MSS/MSI-L) groups. Propensity score matching was used to match clinicopathological factors between the 2 groups. MSI-H patients had a high lymph node harvest (median: 31.0 vs 23.0, P < .001), earlier-stage tumors (P < .001), advanced T stage (89.3% vs 74.0%, P = .018), and poor differentiation (19.6% vs 2.0%, P < .001). Survival analysis showed better survival in the MSI-H group, but the difference was not statistically significant (P = .126). Propensity score matching was performed for significant prognostic factors identified by Cox hazard regression. After the matching, the survival difference by MSI status was estimated to be larger than before, and reached statistical significance (P = .045). In conclusion, after controlling for pathological characteristics, MSI-H could be a potent prognostic factor regarding patient survival.

30 June 2015 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
BKBo Ram Kim
Bo Ram Kim
SOSang Cheul Oh
Sang Cheul Oh
DLDae-Hee Lee
Dae-Hee Lee
JKJung Lim Kim
Jung Lim Kim
SLSuk Young Lee
Suk Young Lee
BMByung Wook Min
Byung Wook Min

23 January 2016 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
JKJung Lim Kim
Jung Lim Kim
DLDae-Hee Lee
Dae-Hee Lee
YNYoo Jin Na
Yoo Jin Na
BKBo Ram Kim
Bo Ram Kim
YJYoon A. Jeong
Yoon A. Jeong
BMByung Wook Min
Byung Wook Min

1 November 2007 in Diseases of the Colon & Rectum
Verified
Journal Article
Closed access
JKJung-Myun Kwak
Jung-Myun Kwak
BMByung-Wook Min
Byung-Wook Min
JLJu-Han Lee
Ju-Han Lee
JCJong-Sang Choi
Jong-Sang Choi
SLSun-Il Lee
Sun-Il Lee
HMHong-Young Moon
Hong-Young Moon
Determined whether differences in expression patterns were associated with clinicopathologic parameters and also which relationship between these two adhesion molecules existed in colorectal cancer. Methods: Expression pattern of E-cadherin and liver intestine-cadherin was investigated immunohistochemically in 207 colorectal cancers along with clinicopathologic parameters. Results: Reduced expression of liver intestine-cadherin was detected in 51 percent (n = 105) of tumors. Such expression was found to be associated with tumoral dedifferentiation (P= 0.015) and in a multivariate analysis was associated with a significant worse overall survival after adjustment for tumor stage, differentiation, and E-cadherin status (hazard ratio, 1.951; 95 percent confidence interval, 1.06-3.592;P= 0.032). Fifteen percent (n = 32) of tumors showed reduced expression of E-cadherin and had relationship with tumoral dedifferentiation (P< 0.001), lymph node metastasis (P= 0.004), and advanced stage (P= 0.029). Reduced expression of E-cadherin was associated with short overall survival (P= 0.028); however, in a multivariate analysis, it was not statistically significant. Conclusions: Reduced expression of liver intestine-cadherin had a significant correlation with tumoral dedifferentiation and short overall survival in this series. In addition, early and frequent loss of liver intestine-cadherin expression might be a more sensitive indicator than E-cadherin to predict more aggressive tumoral behavior. e-mail: gsmin@korea.ac.kr © The ASCRS 2007...

12 September 2016 in Oncology Reports
Verified
Journal Article
Closed access
BKBo Ram Kim
Bo Ram Kim
MKMyoung Hee Kang
Myoung Hee Kang
JKJung Lim Kim
Jung Lim Kim
YNYoo Jin Na
Yoo Jin Na
SPSeong Hye Park
Seong Hye Park
SOSang Cheul Oh
Sang Cheul Oh
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publications

2 March 2022 in Cancers
Verified
Journal Article
Open access
PDF file
JBJun Woo Bong
Jun Woo Bong
JGJeong-An Gim
Jeong-An Gim
YJYeonuk Ju
Yeonuk Ju
CCChinock Cheong
Chinock Cheong
SLSunil Lee
Sunil Lee
Sanghee KangSanghee Kang
Sanghee Kang
In colorectal cancer, whereas mucinous adenocarcinoma (MAC) has several poor clinical prognostic factors compared to adenocarcinoma (AC), the prognosis of MAC remains controversial. We evaluated the prognosis of MAC without distant metastasis and the effects of adjuvant chemotherapy using health insurance registry data managed by South Korea. Patients with colorectal cancer between January 2014 and December 2016 were included (AC, 22,050 [96.8%]; MAC, 729 [3.2%]). We observed no difference in overall survival (OS) between AC and MAC in stages I and II. However, MAC showed a worse OS than AC in stage III disease, especially in patients administered chemotherapy (p < 0.001). These findings persisted after propensity score matching of clinical characteristics between AC and MAC. In addition, transcriptome analysis of The Cancer Genome Atlas (TCGA) data showed increased chemoresistance-associated pathways in MAC compared to AC. In consensus molecular subtypes (CMS) classification, unlike in AC, CMSs 1, 3, and 4 comprised most of MAC and the proportions of CMSs 3 and 4 increased with stage progression. These results suggest clues to overcome resistance to chemotherapy and develop targeted treatments in MAC.